SONOVA HOLDING (OTCMKTS:SONVY - Get Free Report)'s share price crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $60.02 and traded as low as $53.47. SONOVA shares last traded at $53.86, with a volume of 30,420 shares trading hands.
Analyst Upgrades and Downgrades
SONVY has been the subject of several recent analyst reports. Kepler Capital Markets upgraded shares of SONOVA from a "strong sell" rating to a "hold" rating in a report on Friday, June 6th. HSBC lowered shares of SONOVA from a "buy" rating to a "hold" rating in a research note on Wednesday, May 21st. Hsbc Global Res downgraded shares of SONOVA from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, May 21st. Barclays downgraded shares of SONOVA from a "hold" rating to a "strong sell" rating in a research report on Friday, June 20th. Finally, Sanford C. Bernstein upgraded shares of SONOVA from a "hold" rating to a "strong-buy" rating in a report on Friday, July 18th. Four analysts have rated the stock with a sell rating, four have issued a hold rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold".
View Our Latest Report on SONVY
SONOVA Stock Up 2.0%
The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.96 and a current ratio of 1.27. The stock's 50 day moving average is $59.63 and its two-hundred day moving average is $61.72.
SONOVA Increases Dividend
The company also recently disclosed a dividend, which was paid on Wednesday, July 2nd. Investors of record on Tuesday, June 17th were issued a dividend of $0.6243 per share. This is an increase from SONOVA's previous dividend of $0.57. This represents a yield of 99.0%. The ex-dividend date was Monday, June 16th.
SONOVA Company Profile
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading
Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.